These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34834587)

  • 21. Detecting dopaminergic neuronal degeneration using diffusion tensor imaging in a rotenone-induced rat model of Parkinson's disease: fractional anisotropy and mean diffusivity values.
    Liu LX; Du D; Zheng T; Fang Y; Chen YS; Yi HL; He QY; Gao DW; Shi QL
    Neural Regen Res; 2017 Sep; 12(9):1485-1491. PubMed ID: 29089995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atlas-based relaxometry and subsegment analysis of the substantia nigra pars compacta using quantitative MRI: a healthy volunteer study.
    Fujiwara Y; Ishida S; Matta Y; Kanamoto M; Kimura H
    Br J Radiol; 2022 Jul; 95(1135):20210572. PubMed ID: 35357890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining Diffusion Tensor Imaging and Susceptibility Weighted Imaging on the Substantia Nigra of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP)-induced Rhesus Monkey Model of Parkinson's Disease.
    Zhang Q; Li L; Miao B; Niu H
    West Indian Med J; 2015 Dec; 64(5):480-486. PubMed ID: 27400227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease.
    Zhang Y; Wu IW; Buckley S; Coffey CS; Foster E; Mendick S; Seibyl J; Schuff N
    Mov Disord; 2015 Aug; 30(9):1229-36. PubMed ID: 25920732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.
    Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C
    Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study.
    Safai A; Prasad S; Chougule T; Saini J; Pal PK; Ingalhalikar M
    Hum Brain Mapp; 2020 Apr; 41(5):1323-1333. PubMed ID: 31778276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
    Wang C; Fan G; Xu K; Wang S
    Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
    Hope TR; Selnes P; Rektorová I; Anderkova L; Nemcova-Elfmarkova N; Balážová Z; Dale A; Bjørnerud A; Fladby T
    PLoS One; 2019; 14(5):e0217922. PubMed ID: 31150514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
    Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
    Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease.
    Aquino D; Contarino V; Albanese A; Minati L; Farina L; Grisoli M; Romita L; Elia AE; Bruzzone MG; Chiapparini L
    Neurol Sci; 2014 May; 35(5):753-8. PubMed ID: 24337946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
    PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease.
    Menke RA; Jbabdi S; Miller KL; Matthews PM; Zarei M
    Neuroimage; 2010 Oct; 52(4):1175-80. PubMed ID: 20677376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
    Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
    Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
    Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
    J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal silent lacunar infarction is associated with changes to the substantia nigra in patients with early-stage Parkinson's disease: A diffusion kurtosis imaging study.
    Zhang G; Zhang Y; Zhang C; Wang Y; Ma G; Nie K; Xie H; Liu J; Wang L
    J Clin Neurosci; 2016 Nov; 33():138-141. PubMed ID: 27499120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.
    Prakash BD; Sitoh YY; Tan LC; Au WL
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1029-33. PubMed ID: 22705126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion Kurtosis Imaging for Detection of Early Brain Changes in Parkinson's Disease.
    Guan J; Ma X; Geng Y; Qi D; Shen Y; Shen Z; Chen Y; Wu E; Wu R
    Front Neurol; 2019; 10():1285. PubMed ID: 31920913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nigral diffusivity, but not free water, correlates with iron content in Parkinson's disease.
    Langley J; Huddleston DE; Hu X
    Brain Commun; 2021; 3(4):fcab251. PubMed ID: 34805996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.